Postoperative atrial fibrillation.
DOI:
https://doi.org/10.26641/2307-0404.2014.2.28459Keywords:
ischemic heart disease, coronary artery bypass, post-operative arterial fibrillation, cardio-vascular risk, complicationsAbstract
Postoperative arterial fibrillation (AF) is one of the most common complication after cardiac surgery . POAF affect the length of hospital stay, incidence of postoperative stroke and mortality. The main factors of postoperative AF include age, gender, left atrial size, presence of AF before surgery. The most effective drugs to prevent POAF are beta-blockers and amiodarone. In many cases statins, blockers of the renin -angiotensin system are prescribed. Clinical management of patients with POFP and urgency of restoring sinus rhythm are determined by hemodynamic parameters. In unstable hemodynamic condition electrical cardioversion is performed.References
A meta-analysis of prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery / S.M. Bagshaw, P. D.L. Galbraith, B. Mitchell [et al.] // Ann. Thorac. Surg. – 2006. – Vol. 82. – P. 1927-1937.
A multicenter risk index for atrial fibrillation after cardiac surgery / J.P. Mathew, M.L. Fontes, I.C. Tudor [et al.] // JAMA. – 2004. – Vol. 291. – P. 1720-1729.
ACC/AHA Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation // 2004. – Vol. 110. – P. 1168-1176.
АCC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary // Eur. Heart. J. –2006. – Vol. 27. – P. 1979-2030.
American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery / C.W. Hogue, Jr. Lawrence, L. Creswell [et al.] // Chest. – 2005. – Vol. 128. – P. 9-16.
Amiodarone prophylaxis after cardiac surgery: meta-analysis of dose response and timing of initiation / Buckly M.S., Nolan P.E. Jr, Slack M.K. [et al.] // Pharmacotherapy. – 2007. – Vol. 27. – P. 360-368.
Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a metaanalysis / J.D. Aasbo, A.T. Lawrence, K. Krishnan [et al.] // Ann. Inter. Med. – 2005. – Vol. 143. – P. 327–336.
Antiarrhythmic effect of statin therapy and atrial fibrillation / L. Fauchier, B. Pierre, A. de Labriolle [et al.] // J. Am. Coll. Cardiol. 2008. – Vol. 51. – P. 828-835.
Atrial activity during cardioplegia and post¬operative arrhyrhmias / J.C. Mullen, N. Khan, R. Weisel [et al.] // Thorac. Cardiovasc. Surg. – 1987. – Vol. 94. – P. 558-565.
Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation / J.M. Kal¬man, M. Munawar, L.G. Howes [et al.] // Ann. Thorac. Surg. – 1995. – Vol. 60. – P. 1709–1715.
Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization: Multicenter Study of Perioperative Ischemia Research Group / J.P. Mathew, R. Parks, J.S. Savino, A.S. Friedman [et al.] // J. Amer. Med. Assoc. – 1996. – Vol. 276. – P. 300-306.
Atrial fibrillation after cardiac surgery. A major morbid event? / G.H. Almassi, T. Schowalter, A.C. Ni¬colosi [et al.] // Ann. Surg. – 1997. – Vol. 226. – P. 501-513.
Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump? / Y. Enc, B. Ketenci, D. Ozsoy [et al.] // Eur. J. Car¬diothorac. Surg. – 2004. – Vol. 26. – P. 1129-1133.
Atrial fibrillation following cardiac surgery: clinical features and preventive strategies / D. Kai¬re¬vicute. A. Aidietis, Y.H. Gregory // Eur. Heart J. – 2009. – Vol. 30. – P. 410-425.
Atrial fibrillation after off-pump coronary artery surgery: a prospective matched study / T. Turk, H. Vural, C. Eris [et al.] // J. Inter. Med. Res. – 2007. – Vol. 35. – P. 134-142.
Cardiology American Heart Association Task Force on Practice Guidelines Summary and Recom¬mendations: A Report of the American College of ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive Summary / K.A. Eagle, R.A. Guyton, R. Davidoff [et al.] // Circulation. – 1999. – Vol. 100. – P. 1464-1480
Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery / Nasir Shariff, Steven Zelenkofske, Sherrine Eid [et al.] // BMC Cardiovascular Disorders. – 2010. – Vol. 10, N 7.
Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery / Shariff N, Zelenkofske S, Eid S, Weiss MJ, [et al.] // BMC Cardiovasc Disord. – 2010. – Vol. 8, N 10. – 7 p.
Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials / L. Harling, S. Rasoli, J.A. Vecht [et al.] // Heart. – 2011. – Vol. 97, N 20. – P. 1636-1642.
Effect of angiotensin-converting enzyme inhi¬bitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation / C.I. Co¬leman, S. Makanji, J. Kluger, C.M. White // Ann. Phar¬macother. – 2007. – Vol. 41, N 3. – P. 433-437.
Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis / S. Miller, E. Crystal, M. Gar¬finkle [et al.] // Heart. – 2005. – Vol. 91. – P. 618-623.
Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay / W.L. Baker, C.M. White, J. Kluger [et al.] // Heart. Rhythm. – 2007. – Vol. 4. – P. 461-468.
Fish intake and risk of incident atrial fibrillation / D. Mozaffarian, B.M. Dasty, E.B. Rimm [et al.] // Cir¬culation. – 2004. – Vol. 110. – P. 368-373.
Dunning J. Guidelines on the prevention and ma¬nagement of de novo atrial fibrillation after cardiac and thoracic surgery / J. Dunning, T. Treasure, M. Versteegh // Europ. J. Cardiothor. Surg. – 2006. – Vol. 30. – P. 852-872.
Hazards of postoperative atrial arrhythmias / L.L. Cres¬well, R.B. Schuessler, M. Rosenbloom [et al.] // Ann. Surg. – 1993. Vol. 56. – P. 539-549.
Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery / M. Funk, R.N., S.B. Richards, J. Desjardins [et al.] // Amer. J. Crit. Care. – 2003. – Vol. 12. – P. 424-433.
Independent of C-reactive protein statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery / D. Amar, H. Zhang, M. Paul [et al.] // Chest. – 2005. – Vol. 128. – P. 3421-3427.
Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis / D.C. Burges, M.J. Kilborn, A.C. Keech // Eur. Heart. J. – 2006. – Vol. 27. – P. 2846-2857.
Interventions on prevention of post-operative atrial fibrillation in patients undergoing heart surgery. A meta-analysis / E. Crystal, S.J. Connolly, K. Sleik [et al.] // Circulation. – 2002. – Vol. 106. – P. 75-80.
Intra- and postoperative predictors of stroke after coronary artery bypass grafting / D.S. Likosky, B.S. Leavitt, C.A.S. Marrin [et al.] // Ann. Thorac. Surg. – 2003. – Vol. 76. – P. 428-435.
Mads D.M. Engelmann and Jesper Hastrup Svendsen. Inflammation in the genesis and perpetuation of atrial fibrillation / D.M. Mads // Eur. Heart. J. – 2005. – Vol. 26. – P. 2083-2092.
Maisel W.H. Atrial fibrillation after cardiac surgery / W.H. Maisel, J.D. Rawn, W.G. Stevenson // Ann. Intern. Med. – 2001. – Vol. 135. – P. 1061-1073.
Marin F. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting / F. Marin, D.A. Pascual, V. Roldan // Amer. J. Cardiol. – 2006. – Vol. 97. – P. 55-60.
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery / Najmeddine Echahidi, Philippe Pibarot, Gilles O’Hara, Patrick Mathieu // J. Amer. College Cardiology. – 2008. – Vol. 51, N 8. – P. 797-800.
Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting / P.R. Kowey, J.E. Taylor, Sj. Rials [et al.] // Amer. J. Cardiol. 1992. – Vol. 69. – P. 963-965.
Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study / Meh¬met Ozaydin1, Atilla Icli, Habil Yucel [et al.] // Eur. Heart J. 2012.
N-acetylcysteine for the prevention of post¬operative atrial fibrillation: a prospective, rando¬mized, placebo-controlled pilot study / Mehmet Ozaydin, Oktay Peker, Dogan Erdogan [et al.] // Eur. Heart J. – 2008. – Vol. 8. – P. 2-7.
Calo L. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery / L. Calo, L. Bianconi, F. Colvicchi // J. Am. Coll. Cardiol. – 2005. – Vol. 45. – P. 1723-1728.
Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery / Z .Anoar, Thomas A. Schwann [et al.] // Circulation. – 2005. – Vol. 112. – P. 3247-3255.
Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery / G. Mariscalco, R. Lorusso, C. Klersy [et al.] // Ann. Thorac. Surg. – 2007. – Vol. 84. – P. 1158-1164.
Patel A. Is sotalol more effective that β-blockers for prophylaxis of atrial fibrillation during cardiac surgery / A. Patel, J. Dunning // Inter. Cardiovasc. Thorac. Surg. – 2005. – Vol. 4. – P. 147-150.
DiDomenico R.J. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery / R.J. DiDomenico, D. Pharm, M.G. Massad // Ann. Thorac. Surg. – 2005. – Vol. 79. – P. 728–740.
Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery / J. Auer, T. Weber, R. Berent [et al.] // Cardiovasc. Surg. – 2005. – Vol. 46. – P. 583-588.
Postoperative atrial fibrillation and mortality after coronary artery bypass surgery / R.P. Villareal, R. Hari¬haran, B.C. Liu [et al.] // J. Am. Coll. Cardiol. –2004. – Vol. 43. – P. 742–748.
Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized On Versus Off Bypass trial / G.H. Al¬massi, S.A. Pecsi, J.F. Collins // J. Thorac. Cardiovasc. Surg. – 2012. – Vol. 143, N 1. – P. 93-102.
Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. / S.F. Aranki, D.P. Shaw, D.H. Adams [et al.] // Circulation. 1996. – Vol. 94. – P. 390-397.
Ferguson T.B. Jr. Pre- operative β-blocker use and mortality and morbidity following CABG surgery in North America / T.B. Ferguson Jr, L.P. Coombs, E.D. Pe¬terson // JAMA. – 2002. – Vol. 287. – P. 2221-2227.
Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery / T. Kinoshita, T. Asai, T. Suzuki // Eur. J. Cardiothorac. Surg. – 2012. – Vol. 41, N 1. – P. 102-107.
Preoperative statin therapy for patients under¬going cardiac surgery / O.J. Liakopoulos, E.W. Kuhn, I. Slottosch // Cochrane Database Syst. Rev. – 2012. – Vol. 18, N 4. – CD008493.
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study / L.L. Clark, J.S. Ikonomidis, F.A. Crawford Jr. // J. Thorac. Cardiovasc. Surg. – 2006. – Vol. 131. – P. 520-522.
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis / J.S. Healey, A. Baranchuk, E. Crystal [et al.] // J. Am. Coll. Cardiol. – 2005. – Vol. 45. – P. 1832-1839.
Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials / T.C. Andrews, S.C. Reimold, J.A. Berlin [et al.] // Circulation. – 1991. – Vol. 84. – P. III236-III244.
Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: A randomized controlled trial / L.B. Mitchell, D.V. Exner, D.G. Wyse [et al.] // JAMA. 2005. – Vol. 294. – P. 3093-3100.
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 study / G. Patti, M. Chello, D. Candura [et al.] // Circullation. – 2006. – Vol. 114. – P. 1455-1461.
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation / C.G. Koch, L. Li, D.R. Van Wagoner [et al.] // Ann. Thorac. Surg. 2006. – Vol. 82. – P. 1747-1756.
Reston J.T. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting / J.T. Reston, S.J. Tregear, C.M.Turkelson // Ann. Thorac. Sur. – 2003. – Vol. 76. – P. 1510-1515.
Rho R.W. Biphasic versus monophasic shock waveform for the conversion of atrial fibrillation / R.W. Rho, R.L.Dage // Card Electrophysiol Rew. – 2003. – Vol. 7. – P. 290-291.
Rho R.W. The management of atrial fibrillation after cardiac surgery / R.W. Rho // Heart. – 2009. – Vol. 95. – P. 422-429.
Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery / L.A. Mendes, G.P. Connely, P.A. McKenney [et al.] // J. Amer. Coll. Cardiol. – 1995. – Vol. 25. – P. 198-202.
Haan CK.. Role of amiodarone in reducing atrial fibrillation after cardiac surgery in adults / C.K. Haan, S.A.Geraci // Ann. Thorac. Surg. – 2002. – Vol. 73. – P. 1665–1669.
Statins promote potent systemic antioxidant effects through srecific inflammatory pathways / M.H. Shishehbor, M.L. Brennan, R.J. Aviles [et al.] // Cir¬culation. – 2003. – Vol. 108. – P. 426-431.
Stroke after coronary artery bypass: incidence, predictors and clinical outcome / S.C. Stamou, P.C. Hill, G. Dangas [et al.] // Stroke. – 2001. – Vol. 32. – P. 1508-1513.
Stroke after coronary artery bypass grafting: are we forgetting atrial fibrillation? / J.A. Odell, J.L. Black¬shear [et al.] // Ann. Thorac. Surg. – 2001. – Vol. 71. – P. 400-401.
The effects of steroids on the occurrence of post¬operative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial / K. Pra¬songsukarn, J.G. Abel, E. Jamieson [et al.] // J. Thorac. Cardiovasc. Surg. – 2005. – Vol. 130. – P. 93-98.
The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass graf¬ting / S. Bramer, A.H. van Straten, M.A. Soliman Hamad [et al.] // Ann. Thorac. Surg. – 2011. – Vol. 40, N 5. – P. 1185-1190.
he impact of new-onset postoperative atrial fibril¬lation on mortality after coronary artery bypass grafting / S. Bramer, A.H. van Straten, M.A. Soliman Hamad [et al.] // T. Ann. Thorac. Surg. – 2010. – Vol. 90, N 2. – P. 443-449.
24-h in-hospital mortality predictions in coronary artery bypass grafting patients / H. Ahmadi, A. Karimi, S. Davoodi [et al.] // Arch. Med. Res. – 2007. – Vol. 38. – P. 417-423.
Wolf P.A. Atrial fibrillation as an independent risk factor for stroke: the Framingham study / P.A. Wolf, R.D. Abbott, W.B. Kannel // Stroke. – 1991. – Vol. 22. – P. 983–988.
Bagshaw SM, P. Galbraith DL. Mitchell B. A meta-analysis of prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2006;82:1927-37.
Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720–9.
ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation 2004;110:1168-76.
АCC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. Eur. Heart. J. 2006;27:1979-2030.
Hogue CW, Jr., Lawrence L. Creswell. American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest. 2005;128:9-16.
Buckly MS, Nolan PE Jr, Slack MK. Amiodarone prophylaxis after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy. 2007;27:360-8.
Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a metaanalysis. Ann Intern Med. 2005;143:327–36.
Fauchier L, Pierre B, de Labriolle A. Antiar¬rhythmic effect of statin therapy and atrial fibrillation. J Am Coll Cardiol. 2008;51:828-35.
Mullen JC, Khan N, Weisel R. Atrial activity during cardioplegia and postoperative arrhyrhmias. Thorac Cardiovasc Surg 1987;94:558-65.
Kalman JM, Munawar M, Howes LG. Atrial fibrillation after coronary artery bypass grafting is as¬sociated with sympathetic activation. Ann Thorac Surg. 1995;60:1709–15.
Mathew JP, Parks R, Savino JS, Friedman AS. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization: Multicenter Study of Perioperative Ischemia Research Group. J Amer Med Assoc. 1996;276:300-6.
Almassi GH, Schowalter T, Nicolosi AC. Atrial fibrillation after cardiac surgery. A major morbid event? Ann Surg. 1997;226:501-13.
Enc Y, Ketenci B, Ozsoy D. Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump? Eur J Cardiothorac Surg. 2004;26:1129-33.
Kairevicute D, Aidietis A and Gregory Y.H. Atrial fibrillation following cardiac surgery: clinical features and preventive strategies. Europ Heart J. 2009;30:410-25.
Turk T, Vural H, Eris C. Atrial fibrillation after off-pump coronary artery surgery: a prospective matched study. J Intern Med Res. 2007;35:134-42.
Eagle KA, Guyton RA, Davidoff R. Cardio¬logy/American Heart Association Task Force on Practice Guidelines Summary and Recommendations: A Report of the American College of ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive Sum¬mary. Circulation. 1999;100:1464-80.
Nasir Shariff, Steven Zelenkofske, Sherrine Eid. Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery. BMC Cardiovascular Disorders. 2010;10:7
Shariff N, Zelenkofske S, Eid S, Weiss MJ, Mohammed MQ. Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery. BMC Cardiovasc Disord. 20108;10:7.
Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart. 2011 Oct;97(20):1636-42.
Coleman CI, Makanji S, Kluger J, White CM. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Phar¬macother. 2007 Mar;41(3):433-7.
Miller S, Crystal E, Garfinkle M. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart. 2005;91:618-23.
Baker WL, White CM, Kluger J. Effect of pe¬rioperative corticosteroid use on the incidence of post¬cardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007;4:461-8.
Mozaffarian D, Dasty BM, Rimm EB. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110:368-373.
Dunning J, Treasure T, Versteegh M Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery et al. Europ J Cardiothor Surg. 2006;30:852-72.
Creswell LL, Schuessler RB, Rosenbloom M. Hazards of postoperative atrial arrhythmias. Ann Surg. 1993;56:539-49.
Funk M, RN, Richards SB., Desjardins J. In¬cidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery. Amer J Crit Care 2003;12:424-33.
Amar D, Zhang H, Paul M. Independent of C-reactive protein statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery. Chest. 2005;128:3421-7.
Burges DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27:2846-57.
Crystal E, Connolly SJ, Sleik K. Interventions on prevention of post-operative atrial fibrillation in patients undergoing heart surgery. A meta-analysis. Circulation. 2002;106:75-80.
Likosky DS, Leavitt BS, Marrin CAS. Intra- and postoperative predictors of stroke after coronary artery bypass grafting. Ann Thorac Surg. 2003;76:428-35.
Mads D.M. Engelmann and Jesper Hastrup Sven¬d¬sen. Inflammation in the genesis and perpetuation of atrial fibrillation. Europ Heart J 2005;26:2083-92.
Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061-73.
Marin F, Pascual DA, Roldan V et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Amer J Cardiol 2006;97:55-60.
Najmeddine Echahidi, Philippe Pibarot, Gilles O’Hara, Patrick Mathieu.Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery. Journal of the American College of Cardiology. 2008;51(8):797–800.
Kowey PR, Taylor JE, Rials Sj. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Amer J Cardiol. 1992;69:963-5.
Mehmet Ozaydin1, Atilla Icli, Habil Yucel et al. Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a ran¬do¬mized, double-blind, placebo-controlled study. European Heart Journal. 2012.
Mehmet Ozaydin, Oktay Peker, Dogan Erdogan. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. European Heart Journal. 2008;8:2-7.
Calo L, Bianconi L, Colvicchi F. N-3 fatty acids for the prevention of atrial fibrillation after coronary ar¬tery bypass surgery. J Am Coll Cardiol. 2005;45:1723-28.
Anoar Z, Thomas A. Schwann. Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery. Circulation. 2005;112:3247-55.
Mariscalco G, Lorusso R, Klersy C et al. Ob¬servational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007;84:1158 –64.
Patel A, Dunning J. Is sotalol more effective that β-blockers for prophylaxis of atrial fibrillation during cardiac surgery. Interact Cardiovasc Thorac Surg. 2005;4:147-50.
DiDomenico RJ, Pharm D, Massad MG, Pharma¬cologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg. 2005;79:728–40.
Auer J, Weber T, Berent R. Postoperative atrial fibrillation independently predicts prolongation of hos¬pital stay after cardiac surgery. Cardiovasc Surg. 2005;46:583-8.
Villareal RP, Hariharan R, Liu BC. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–8.
Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized On Versus Off Bypass trial. J Thorac Cardiovasc Surg. 2012 Jan;143(1):93-102.
Aranki SF, Shaw DP, Adams DH, et al. Pre¬dictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Cir¬culation. 1996;94:390-7.
Ferguson TB Jr, Coombs LP, Peterson ED. Pre- operative β-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221-7.
Kinoshita T, Asai T, Suzuki T, Kambara A, Mat¬subayashi K. Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg. 2012;41(1):102-7.
Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients un¬dergoing cardiac surgery. Cochrane Database Syst Rev. 2012 Apr 18;4:CD008493.
Clark LL, Ikonomidis JS, Crawford FA Jr. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients un¬dergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc SurG. 2006;131:520-2.
Healey JS, Baranchuk A, Crystal E. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-ana¬lysis. J Am Coll Cardiol. 2005;45:1832-9.
Andrews TC, Reimold SC, Berlin JA. Prevention of supraventricular arrhythmias after coronary artery by¬pass surgery. A meta-analysis of randomized control trials. Circulation. 1991;84(3):236-44.
Mitchell L.B ,. Exner DV, Wyse DG. Prophy¬lactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replace¬ment, or repair. PAPABEAR: A randomized controlled trial. JAMA. 2005;294:3093-100.
Patti G, Chello M, Candura D et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 study. Circullation. 2006;114:1455-61.
Koch CG, Li L, Van Wagoner DR. Red cell trans¬fusion is associated with an increased risk for post¬operative atrial fibrillation. Ann Thorac Surg. 2006;82:1747-56.
Reston JT, Tregear SJ, Turkelson CM. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Sur. 2003;76:1510-5.
Rho RW, Dage RL. Biphasic versus monophasic shock waveform for the conversion of atrial fibrillation. Card Electrophysiol Rew. 2003;7:290-1.
Rho RW. The management of atrial fibrillation after cardiac surgery. Heart 2009;95:422-9.
Mendes LA, Connely GP, McKenney PA. Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Amer Coll Cardiol. 1995;25:198-202.
Haan CK, Geraci SA. Role of amiodarone in reducing atrial fibrillation after cardiac surgery in adults. Ann Thorac Surg. 2002; 73:1665–9.
Shishehbor MH, Brennan ML, Aviles RJ. Statins promote potent systemic antioxidant effects through sre¬cific inflammatory pathways. Circulation 2003;108:426-31.
Stamou SC, Hill PC, Dangas G. Stroke after coronary artery bypass: incidence, predictors and clinical outcome. Stroke. 2001;32:1508-13.
Odell JA , Blackshear JL. Stroke after coronary artery bypass grafting: are we forgetting atrial fibrillation? Ann Thorac Surg. 2001;71:400-1
Prasongsukarn K, Abel JG, Jamieson E. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial. J Thorac Car¬diovasc Surg. 2005;130:93-98.
Bramer S, van Straten AH, Soliman Hamad MA. The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg. 2011;40(5):1185-90.
Bramer S, van Straten AH, Soliman Hamad MA. The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg. 2010;90(2):443-9.
Ahmadi H, Karimi A, Davoodi S. 24-h in-hospital mortality predictions in coronary artery bypass grafting patients. Arch Med Res. 2007;38:417-23.
Wolf PA, Abbott RD, Kannel WB. Atrial fib¬rillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991; 22:983–8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
